In an analysis of the Oncomine dataset, focusing on 5 histologically distinct solid tumors (bladder cancer, glioblastoma, melanoma, breast, invasive-ductal cancer, and lung carcinoma), ACCN4-expression was neither upregulated nor downregulated, compared to normal tissue [96]. This evidence concerns the gene ASIC4 and urinary bladder cancer.